Automated And Closed Cell Therapy Processing Systems Market Report 2026 Market Outlook Supported By A Forecast 16.7% CAGR

The automated and closed cell therapy processing systems market is set to experience significant expansion over the coming years, driven by technological advancements and growing demand in the cell therapy sector. This overview explores the market's projected growth, leading players, emerging trends, and segment breakdowns to provide a comprehensive understanding of the industry's future trajectory.

Projected Market Growth for Automated and Closed Cell Therapy Processing Systems
The market for automated and closed cell therapy processing systems is anticipated to grow rapidly, reaching a valuation of $3.34 billion by 2030. This expansion reflects a compound annual growth rate (CAGR) of 16.7% during the forecast period. Several factors contribute to this strong growth, including the development of integrated closed-system platforms, innovations in robotics and microfluidics, the increasing number of cell and gene therapy pipelines, tighter regulatory standards, and the rising presence of contract manufacturing organizations (CMOs) specializing in cell therapies. Key trends shaping the market include the growing adoption of single-use and closed systems, the push for automated workflows in cell therapy, enhanced safety measures to reduce contamination risks, the integration of multi-step cell processing platforms, and expanding applications in regenerative medicine and oncology.

Download a free sample of the automated and closed cell therapy processing systems market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27214&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Leading the Automated and Closed Cell Therapy Processing Systems Market
The competitive landscape of this market features prominent players such as Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., and Autolus Therapeutics Plc.

A notable recent development occurred in March 2024, when Donaldson Company Inc., a US-based filtration firm, acquired Univercells Technologies for $157.28 million (€136 million). This strategic move aims to broaden Donaldson's life sciences portfolio by incorporating Univercells Technologies' automated and closed biomanufacturing platforms, thereby delivering comprehensive solutions for cell and gene therapy production. Univercells Technologies is headquartered in Belgium and specializes in automated and closed cell therapy processing systems.

View the full automated and closed cell therapy processing systems market report:
https://www.thebusinessresearchcompany.com/report/automated-and-closed-cell-therapy-processing-systems-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends and Opportunities in Automated and Closed Cell Therapy Processing Systems
Key players in the market are heavily focused on advancing technologies that simplify cell processing while reducing manual labor and contamination risks. Automated cell preparation platforms are central to these efforts, offering streamlined processes to isolate, prepare, and analyze cells efficiently for both clinical and research purposes.

For example, in October 2024, Sino-Biocan Biotechnology Ltd., a biotech company based in China, introduced the WUKONG Automated, Closed, Integrated Cell Processing System. This fully automated, closed platform represents a significant breakthrough in cell therapy manufacturing by managing the entire process from blood collection to cell culture and final filling. Designed for use in hospitals, pharmaceutical R&D, and contract development and manufacturing organizations, the system enhances operational efficiency, lowers contamination risks, and ensures GMP-grade consistency through intelligent controls and real-time monitoring.

Detailed Breakdown of Automated and Closed Cell Therapy Processing Systems Market Segments
This market is segmented based on several key categories:

By Component:
- Software
- Hardware
- Consumables

By Technology:
- Microfluidics
- Robotics
- Bioreactors
- Single-Use Technology
- Three-Dimensional (3D) Cell Culture

By Workflow:
- Cryopreservation
- Separation
- Fill-Finish
- Expansion
- Apheresis
- Other Workflows

By Application:
- Oncology
- Regenerative Medicine
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases

By End User:
- Pharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Contract Manufacturing Organizations
- Hospitals

Subsegments include:

Software Types:
- Process Control Software
- Data Management Software
- Quality Monitoring Software
- Workflow Automation Software
- Integration Software

Hardware Types:
- Cell Separation Devices
- Bioreactors
- Fluid Handling Systems
- Centrifuges
- Tubing and Connectors

Consumables:
- Sterile Bags
- Culture Media
- Reagents and Buffers
- Filters and Cartridges
- Single-Use Tubing Sets

This comprehensive segmentation provides a clear picture of the diverse technologies, applications, and users driving the growth of the automated and closed cell therapy processing systems market.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.